Increased levels of the chemokines GROα and MCP-1 in sputum samples from patients with COPD

SL Traves, SV Culpitt, REK Russell, PJ Barnes… - Thorax, 2002 - thorax.bmj.com
SL Traves, SV Culpitt, REK Russell, PJ Barnes, LE Donnelly
Thorax, 2002thorax.bmj.com
Background: Patients with chronic obstructive pulmonary disease (COPD) have increased
numbers of neutrophils and macrophages in their lungs. Growth related oncogene-α (GROα)
attracts neutrophils, whereas monocyte chemoattractant protein-1 (MCP-1) attracts
monocytes that can differentiate into macrophages. The aim of this study was to determine
the concentration of GROα and MCP-1 in bronchoalveolar lavage (BAL) fluid and sputum
from non-smokers, healthy smokers and patients with COPD, and to see if there was a …
Background: Patients with chronic obstructive pulmonary disease (COPD) have increased numbers of neutrophils and macrophages in their lungs. Growth related oncogene-α (GROα) attracts neutrophils, whereas monocyte chemoattractant protein-1 (MCP-1) attracts monocytes that can differentiate into macrophages. The aim of this study was to determine the concentration of GROα and MCP-1 in bronchoalveolar lavage (BAL) fluid and sputum from non-smokers, healthy smokers and patients with COPD, and to see if there was a correlation between the concentrations of these chemokines, lung function, and numbers of inflammatory cells.
Methods: BAL fluid and sputum from non-smokers (n=32), healthy smokers (n=36), and patients with COPD (n=40) were analysed for the presence of GROα and MCP-1 using ELISA. Cells counts were performed on the samples and correlations between the concentrations of these chemokines, lung function, and inflammatory cells observed.
Results: Median (SE) GROα and MCP-1 levels were significantly increased in sputum from patients with COPD compared with non-smokers and healthy smokers (GROα: 31 (11) v 2 (2) v 3 (0.8) ng/ml; MCP-1: 0.8 (0.4) v 0.2 (0.1) v 0.1 (0.04) ng/ml, p<0.05), but not in BAL fluid. There were significant negative correlations between both GROα and MCP-1 levels in sputum and forced expiratory volume in 1 second (FEV1) % predicted (GROα: r=–0.5, p<0.001; MCP-1: r=–0.5, p<0.001), together with significant positive correlations between GROα and MCP-1 and neutrophil numbers in sputum (GROα: r=0.6, p<0.001; MCP-1: r=0.4, p<0.01).
Conclusion: These results suggest that GROα and MCP-1 are involved in the migration of inflammatory cells, thus contributing to the inflammatory load associated with COPD.
thorax.bmj.com